細胞シグナル伝達は、細胞の中核的な動作を指示し、他のすべての活動を同期させる通信システムの一部です。細胞プロセスの解釈と細胞機能の調整は、組織の修復、免疫、最適な組織恒常性を理解するために必要です。シグナル伝達経路は、一般的に細胞シグナル伝達経路と呼ばれ、環境からの合図と、それが引き起こす細胞反応を結び付けます。これらのシグナル伝達経路は、相互作用したり、特定の場所に移動したり、変化したりできるタンパク質で構成されています。内分泌、傍分泌、自己分泌、傍分泌の細胞シグナル伝達は、数多く存在するシグナル伝達の一部です。
糖尿病や自己免疫疾患などの慢性疾患の治療と診断を改善するために行われている膨大な研究は、細胞シグナル伝達の世界市場に利益をもたらしています。細胞シグナル伝達に関する研究は、タンパク質シグナル伝達の偏向を引き起こす可能性のある突然変異によって引き起こされるシグナル伝達経路の誤りを理解するための取り組みの結果として拡大しました。世界の細胞シグナル伝達市場を推進する重要な要素は、慢性疾患の世界的な蔓延の増加です。細胞シグナル伝達業界は、一部の疾患の根本原因を理解するために必要な細胞シグナル伝達の広範な研究開発の恩恵を受けています。さらに、細胞シグナル伝達市場は、細胞ベースの研究に対する政府の資金の増加、細胞ベースの研究機器の技術開発、および最終用途産業の拡大の恩恵を受けています。
The rising number of people with chronic illnesses is a primary driver of the cell signaling market's expansion. Cell signaling research and therapeutics are predicted to be used more frequently as a result of the rising frequency of chronic illnesses, fueling market expansion. Cell signaling research and development is receiving more financing globally, which accelerates the market's expansion. In order to perform research and development operations in cell signaling and produce better and more inventive therapeutics, academics and biotech businesses have been offered financing by the governments of numerous nations. The market for cell signaling is expanding at an even faster rate due to technological developments.
The expansion of the worldwide cell signaling market is significantly constrained by a number of unfavorable aspects. The market's expansion is constrained by standards and laws as well as a lack of competent staff. The market's expansion is also being constrained by the high cost of cell signalling systems and negative public perceptions of stem cell signaling research. The total expansion of the global cell signalling market is also anticipated to be constrained by ethical issues surrounding research on embryonic stem cells. However, the global market share for cell signaling would have strong development possibilities due to the utilization of microfluidics in cell biology research projects and the growing number of emerging markets. The cost of these systems is also quite high.
Microfluidics' emergence as a research tool in the field of cell biology presents a promising potential for market participants in the cell signalling industry. A medical or biotechnological researcher employs specialized antibodies, reagents, test kits, and equipment to determine cell signaling pathways and responses. A vital component of biological life is cell signaling. It aids cells by enabling them to feel and react to their environment, paving the way for growth, development, and immunity.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion) |
| Segmentation | By Product, By Signaling Type, By Pathway, By Technology, By Application, By Region. |
| By Product |
|
| By Signaling Type |
|
| By Pathway |
|
| By Technology | |
| By Application |
|
| By Region |
|
The cell signaling market is expected to reach USD 4.22 billion by the end of 2023.
Single-cell analysis has gained significant attention is a key trend gaining popularity.
The global cell signaling market size was valued at USD 3.46 billion in 2020, and projected to reach USD 6.27 billion by 2029, with a CAGR of 6.83% from 2022 to 2029.
The global market is fragmented in nature with the presence of various key players such as Merck KGaA, Becton Dickinson and Company, Beckman Coulter, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., PerkinElmer Inc., Promega Corporation, Bio-Techne Corporation, Cell Signaling Technology, Inc., Cell Biolabs, BioVision, Tonbo Biosciences
The North America dominated the global industry in 2021 and accounted for the maximum share of more than 51% of the overall revenue.
The consumables category, which accounted for the greatest market share by product in 2021, is predicted to maintain its dominance throughout the forecast period. The segment's growth rate is accelerated by the growing number of advances in genomics and proteomics, as well as by the growing emphasis on personalized medicine and targeted therapeutics. A good CAGR is predicted for the instruments sector throughout the projected period due to factors including technological developments, increased need for automated systems, and rising POC diagnostics demand.
Endocrine signaling is predicted to have the highest revenue share over the forecast period. The system is able to communicate and transfer information from one region of the body to another by providing chemical signals known as hormones. The need for endocrine signaling is increased by the presence of this component. One of the main factors driving the market's growth is the rising frequency of endocrine-related conditions such adrenal insufficiency, Cushing's disease, gigantism, hypothyroidism, and hyperthyroidism.
The AKT pathway is expected to have considerable expansion in the near future. The AKT signaling pathway, also known as the survival route, is responsible for cell growth, reduced apoptotic signaling, and greater proliferation. The AKT signaling pathway is the one that is dysregulated the most frequently in the most prevalent cancer forms. The predicted development of commercial diagnostic tests based on the down-regulation of the AKT pathway is expected to cause the cell signaling industry to grow throughout the course of the anticipated timeframe.
According to technology, the flow cytometry category accounted for the biggest market share globally in 2021 and is anticipated to grow at a robust CAGR over the projected period. The demand for cell-based assays is on the rise, along with technological developments, the prevalence of chronic diseases is rising, personalized medicine is becoming more important, research and development funding is rising, and there are more academic and industrial partnerships than ever before. During the forecast period, the research sector is anticipated to account for a large portion of the worldwide cell signaling market by application. Technology advances, a growing emphasis on personalized medicine and targeted therapies, a rise in interest in regenerative medicine, an increase in the prevalence of chronic diseases, the demand for therapies that target cell signaling pathways, and rising funding for research and development are some of the main factors driving the segment's growth. [caption id="attachment_28871" align="aligncenter" width="1920"]
Geographically, the cell signaling market is segmented into North America, South America, Europe, APAC and MEA.
Given that North America holds a sizable 51% market share in cell signaling, it is expected that this trend will significantly diverge during the forecast period. A strong infrastructure for research and development and the presence of some of the top brains in the world in the subject are both contributing to the growth of the North American cell signaling sector. The growth of the market is being driven by the development of the biopharmaceutical industries and advancements in cell-based research instruments.
Asia-Pacific is thought to be seeing the market's quickest development given its dense population. In addition, the rising prevalence of chronic diseases, rising R&D expenditures, developing key player partnerships with regional suppliers, rising geriatric population, and advancing life science infrastructure are all contributing to the region's cell signaling market growth.
[caption id="attachment_28873" align="aligncenter" width="1920"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.